Skip to main content

The Clinical Diagnosis of Androgen Deficiency

  • Chapter
  • First Online:
Androgen Deficiency and Testosterone Replacement

Abstract

Androgen deficiency can present in a variety of ways. It is important for the clinician to be familiar with the many manifestations of hypogonadism. The clinical diagnosis can be challenging, even with a properly performed history and physical examination. Pathologic presentations can be effectively classified by the body system in which they originate. A patient’s age can also change the particular constellation of androgen deficiency symptoms. This chapter reviews common clinical presentations of androgen deficiency in both of these contexts.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123–35.

    Article  PubMed  CAS  Google Scholar 

  2. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2006;91(6):1995–2010.

    Article  PubMed  CAS  Google Scholar 

  3. Heinemann LA, Saad F, Zimmermann T, et al. The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes. 2003;1:15.

    Article  PubMed  Google Scholar 

  4. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49(9):1239–42.

    Article  PubMed  CAS  Google Scholar 

  5. Corona G, Mannucci E, Petrone L, et al. ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction. J Sex Med. 2006;3(4):706–15.

    Article  PubMed  Google Scholar 

  6. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–30.

    Article  PubMed  CAS  Google Scholar 

  7. Bhasin S, Basaria S. Diagnosis and treatment of hypogonadism in men. Best Pract Res Clin Endocrinol Metab. 2011;25(2):251–70.

    Article  PubMed  CAS  Google Scholar 

  8. Arver S, Lehtihet M. Current guidelines for the diagnosis of testosterone deficiency. Front Horm Res. 2009;37:5–20.

    Article  PubMed  CAS  Google Scholar 

  9. Pallais JC, Au M, Pitteloud N, Seminara S, Crowley WF. Kallmann syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2007.

    Google Scholar 

  10. Wikstrom AM, Dunkel L. Klinefelter syndrome. Best Pract Res Clin Endocrinol Metab. 2011;25(2):239–50.

    Article  PubMed  Google Scholar 

  11. Brauner R, Neve M, Allali S, et al. Clinical, biological and genetic analysis of anorchia in 26 boys. PLoS One. 2011;6(8):e23292.

    Article  PubMed  CAS  Google Scholar 

  12. Pinsky MR, Hellstrom WJ. Hypogonadism, ADAM, and hormone replacement. Ther Adv Urol. 2010;2(3):99–104.

    Article  PubMed  CAS  Google Scholar 

  13. Corona G, Mannucci E, Ricca V, et al. The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. Int J Androl. 2009;32(6):720–8.

    Article  PubMed  CAS  Google Scholar 

  14. Hellstrom WJ, Paduch D, Donatucci CF. Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review. Int Urol Nephrol. 2012;44(1):61–70.

    Article  PubMed  CAS  Google Scholar 

  15. Mulhall JP, Valenzuela R, Aviv N, Parker M. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction. Urology. 2004;63(2):348–52.

    Google Scholar 

  16. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2004;172(2):658–63.

    Article  PubMed  CAS  Google Scholar 

  17. Costa C, Virag R. The endothelial-erectile dysfunction connection: an essential update. J Sex Med. 2009;6(9):2390–404.

    Article  PubMed  CAS  Google Scholar 

  18. Traish AM, Miner MM, Morgentaler A, Zitzmann M. Testosterone deficiency. Am J Med. 2011;124(7):578–87.

    Article  PubMed  CAS  Google Scholar 

  19. Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab. 1999;84(2):573–7.

    Article  PubMed  CAS  Google Scholar 

  20. Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 2002;87(11):5001–7.

    Article  PubMed  CAS  Google Scholar 

  21. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–80.

    Article  PubMed  CAS  Google Scholar 

  22. Laaksonen DE, Niskanen L, Punnonen K, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003;149(6):601–8.

    Article  PubMed  CAS  Google Scholar 

  23. Somani B, Khan S, Donat R. Screening for metabolic syndrome and testosterone deficiency in patients with erectile dysfunction: results from the first UK prospective study. BJU Int. 2010;106(5):688–90.

    Article  PubMed  Google Scholar 

  24. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006;91(3):843–50.

    Article  PubMed  CAS  Google Scholar 

  25. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols HA. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab. 2002;87(8):3632–9.

    Article  PubMed  CAS  Google Scholar 

  26. Malkin CJ, Pugh PJ, Morris PD, et al. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart. 2004;90(8):871–6.

    Article  PubMed  CAS  Google Scholar 

  27. Heufelder AE, Saad F, Bunck MC, Gooren L. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl. 2009;30(6):726–33.

    Article  PubMed  CAS  Google Scholar 

  28. Vermeulen A. Androgen secretion after age 50 in both sexes. Horm Res. 1983;18(1–3):37–42.

    Article  PubMed  CAS  Google Scholar 

  29. Bhasin S. Regulation of body composition by androgens. J Endocrinol Invest. 2003;26(9):814–22.

    PubMed  CAS  Google Scholar 

  30. Khaw KT, Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol. 1992;2(5):675–82.

    Article  PubMed  CAS  Google Scholar 

  31. Wang C, Swerdloff RS, Iranmanesh A, et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000;85(8):2839–53.

    Article  PubMed  CAS  Google Scholar 

  32. Michael H, Harkonen PL, Vaananen HK, Hentunen TA. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res. 2005;20(12):2224–32.

    Article  PubMed  CAS  Google Scholar 

  33. Bassil N. Late-onset hypogonadism. Med Clin North Am. 2011;95(3):507–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wayne J. G. Hellstrom MD, FACS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mitchell, G.C., Serefoglu, E.C., Hellstrom, W.J.G. (2013). The Clinical Diagnosis of Androgen Deficiency. In: Hellstrom, W. (eds) Androgen Deficiency and Testosterone Replacement. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-179-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-179-0_3

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-178-3

  • Online ISBN: 978-1-62703-179-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics